Clincosm LogoSign in Get a demo

ankylosing spondylitis (as)

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Upadacitinib Tablets to Assess Adverse Events and Change in

Recruiting
  • Rheumatoid Arthritis (RA)
  • +3 more
    • Bucheon, Gyeonggido, Korea, Republic of
    • +3 more
    Nov 8, 2022

    Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS) Trial in Marseille (blood samples)

    Completed
    • Axial Spondyloarthritis (axSpA)
    • Ankylosing Spondylitis (AS)
    • blood samples
    • Marseille, France
      Assistance Publique Hopitaux de Marseille
    Aug 31, 2022

    Adalimumab on Health Outcomes in Chinese Immune-Mediated

    Completed
    • Ankylosing Spondylitis (AS)
    • +2 more
      • Shenzhen, Guangdong, China
      • +9 more
      Jul 6, 2022

      Ankylosing Spondylitis (AS) Trial in Wuhan (Secukinumab 300mg s.c., Secukinumab 150mg s.c.)

      Recruiting
      • Ankylosing Spondylitis (AS)
      • Secukinumab 300mg s.c.
      • Secukinumab 150mg s.c.
      • Wuhan, Hubei, China
      • +2 more
      Mar 20, 2022

      Investigate Clinical REsponses in Ankylosing Spondylitis

      Completed
      • Ankylosing Spondylitis (AS)
        • Hualien City, Taiwan
          Hualien Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation
        Nov 18, 2021

        Adherence in Population of Spondylarthritis Patients Treated

        Completed
        • Spondylarthritis
        • +2 more
          • Kemerovo, Kemerovskaya Oblast, Russian Federation
          • +13 more
          Oct 6, 2020

          Ankylosing Spondylitis (AS) Trial ( for risankizumab, risankizumab)

          Completed
          Has Results
          • Ankylosing Spondylitis (AS)
          • (no location specified)
          May 30, 2019